Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.

About REPROCELL

Make an inquiry

REPROCELL Corporate News (6)

REPROCELL and Fox Chase Cancer Center Partner to Open Multi-Site Biosample Repository in India

REPROCELL and Fox Chase Cancer Center Form Strategic Alliance to Accelerate Biomarker and Genetic Discovery

REPROCELL Europe’s CEO Dr David Bunton presented at NC3Rs workshop: Human tissue models for cancer research

REPROCELL Inc CEO meets with Scottish Cabinet Secretary Fiona Hyslop in Japan

Scottish Enterprise Association Honours REPROCELL with Annual Awards Nomination

Prof Stefan Przyborski to chair the SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb)

Notice of formation of contract with Healios K.K. for testing services for regenerative pharmaceutical products

Notice of formation of contract with FANCL Corp. for human iPS cell-derived model cell development

Announcement on the initiation of a new business from the collaboration and commercialization agreement with Steminent Biotherapeutics Inc. for cell therapy

REPROCELL Europe wins CV Technology Innovator Awards 2016 for Alvetex

Prof Stefan Przyborski speaking at BBS 2016 Biennial Meeting

REPROCELL Europe’s (formerly Reinnervate’s) CSO Prof Stefan Przyborski to give an Alvetex Seminar at the University of Oxford, 24 May 2016

Latest Proteon and Biopta publication demonstrates Proteon's Vonapanitase effects in human cephalic veins

Proteon and Biopta publication shows promising nonclinical results on Proteon's Vonapanitase

Reinnervate Ltd wins Corporate Vision’s 2015 Technology Innovator Award for Alvetex

Alvetex in Space

REPROCELL acquires Biopta to expand its drug discovery services

Biopta co-authors research in the European Respiratory Journal

Publication of Paper on “3D culture model construction of mouse neurons” in Neuroscience Letters

A Joint Development with the National Cancer Center Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality

Subscribe to receive updates